Table 2. Demographic and clinical characteristics of the HIV-1/HCV coinfected patients under HAART in group A (Pat# 1-5) and group B (Pat# 6-8).
| Pat# | Gender | Genotype | HCV viremia | ALT | CD4 | CD8 | ARV before HAART | ||||
| T0 | T1 | T0 | T1 | T0 | T1 | T0 | T1 | ||||
| 1 | M | 1 | 1 | 1 | 43 | 350 | 40 | 179 | 698 | 874 | 2 |
| 2 | M | 1 | 1 | 1 | 63 | 210 | 29 | 176 | 554 | 771 | 0 |
| 3 | M | 3 | 2 | 3 | 54 | 56 | 97 | 261 | 411 | 851 | 4 |
| 4 | F | 1 | 1 | 3 | 362 | 310 | 260 | 413 | 611 | 340 | 2 |
| 5 | M | 1 | 3 | 3 | 74 | 48 | 105 | 630 | 2258 | 1461 | 3 |
| 6 | F | 3 | 1 | 3 | 117 | 310 | 145 | 189 | 762 | 709 | 5 |
| 7 | M | 1 | 3 | 3 | 217 | 327 | 217 | 305 | 1365 | 998 | 6 |
| 8 | M | 1 | 3 | 3 | 40 | 42 | 290 | 266 | 1455 | 756 | 1 |
Units used. Age:years; ALT levels: units/L; Cell counts: cells/µl; HCV viremia: log of the limiting dilution titer; ARV before HAART: years.
Pat#: Patient number.